Lidds AB Logo

Lidds AB

LIDDS

Overview

Corporate Details

ISIN(s):
SE0001958612
LEI:
549300YYW8B918K7UN72
Country:
Sweden
Address:
Box 12040, 112 40 Stockholm
Sector:
Health Care
Industry:
Biotechnology

Description

Lidds AB develops innovative drug delivery technologies for cancer treatment.

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
No filings match the current criteria.

Insider Transactions

Date Insider Name Position Type Shares Value
2023-02-14 Anders Månsson Other Buy 100,000 140,000.00 SEK
2023-02-10 Matthew Lindon Other Buy 71,428 99,999.20 SEK
2023-02-09 Daniel Lifveredson Other Other 150,000 210,000.00 SEK
2022-12-16 Daniel Lifveredson Other Sell 435,254 826,982.60 SEK
2022-12-16 Daniel Lifveredson Other Buy 435,254 826,982.60 SEK
2022-06-02 Galba Holding AB Other Buy 750,000 4,500,000.00 SEK
2022-03-08 Jan Törnell Other Buy 5,000 32,500.00 SEK
2021-06-30 Nina Herne Other Other 100,000 116,000.00 SEK
2021-06-03 Daniel Lifveredson Other Buy 435,254 4,483,116.20 SEK
2021-05-31 Maria Forss Other Buy 2,300 29,992.00 SEK

Peer Companies

Company Country Ticker View
ANIMALCARE GROUP PLC Logo ANIMALCARE GROUP PLC United Kingdom ANCR
Annexin Pharmaceuticals AB Logo Annexin Pharmaceuticals AB Sweden ANNX
Apontis Pharma AG Logo Apontis Pharma AG Germany APPH
Aptahem AB Logo Aptahem AB Sweden APTA
Arctic Bioscience Logo Arctic Bioscience Norway ABS
ArcticZymes Technologies Logo ArcticZymes Technologies Norway AZT
argenx SE Logo argenx SE Netherlands (Kingdom of the) 1AE
ARIX BIOSCIENCE PLC Logo ARIX BIOSCIENCE PLC United Kingdom ARIX
AroCell AB Logo AroCell AB Sweden AROC
Arterra Bioscience Logo Arterra Bioscience Italy ABS